click below
click below
Normal Size Small Size show me how
375 Exam 1
COPD, Pulmonary Hypertension
| Term | Definition |
|---|---|
| high CO2 | hypercapnic, give a bipap |
| copd exacerbation | avoid opioids (lead to less ventilation), no benzodiazepines |
| copd diet teaching | diet, oral hygiene before meals, small frequent meals, high calories and protein, avoid exercise 1 hour before and after meals, avoid gassy foods and carbonation, avoid high fiber (causing bloating and more pressure0 |
| fluid copd teaching | increase fluid intake to thin mucus, avoid drinking fluids while eating |
| infection copd teaching | report increase in sputum, fever and worsened dyspnea |
| meds copd teaching | albuterol used for shortness of breath |
| pursed lip breathing | inhale for 2 seconds, exhale 4 seconds with pursed lips; helps decrease shortness of breath, prevents air way collapse and airway trapping |
| huff coughing | cough out thick mucus; sit upright in chair, feet shoulder width, lean forward, deep slow inhalation through mouth and diaphragm muscle, hold breath 2 -3 seconds and forcefully exhale, repeat once or twice to clear |
| chronic bronchitis | daily productive cough for three months or more in at least two consecutive years, damaging to the airways |
| bronchitis manifestations | overweight and cyanotic, elevated hemoglobin, peripheral edema, rhonchi and wheezing |
| emphysema | permanent enlargement and destruction of airspaces distal to the terminal bronchiole |
| emphysema manifestations | older and thin, severe dyspnea, quiet chest |
| copd manifestations | underweight, dyspnea on exertion, SOB, progressive cough and sputum, air hunger, tripod position and barrel chest |
| diagnosis copd | pulmonary function's test, chest xray, test cat, echo |
| forced vital capacity (FVC) | maximum volume of air that can be forcibly expired (3 seconds) |
| forced expiratory volume in 1 second (FEV1) | volume of air that can be expired in the first second of a forced expiration, 70% or above |
| increased residual volume copd | air left in the lungs after forced exhalation |
| spirometry | confirms presence of airflow obstruction |
| copd alterations in ABG | decreased O2, increased CO2, decreased pH, increased HCO3 |
| 6 minute walk test | measures distance an individual is able to walk over a total of 6 minutes, self paced, exercise is a predictor of risk for mortality, can determine functional status and response to treatment |
| risk modification copd | smoking cessation, hand washing, avoid irritants, vaccines, Tdap vaccination |
| bronchodilators | preferred to improve ventilation, decrease dyspnea and increase FEV |
| SABA | short acting bronchodilator agonist - rescue inhaler; albuterol, makes you anxious |
| LABA | long acting bronchodilator agonist, maintenance inhaler; salmeterol |
| anticholinergic, muscarinic | block acetylcholine, decrease mucus production (end in ium) |
| SAMA | short acting muscarinic antagonist; ipratropium |
| LAMA | long acting muscarinic antagonist; tiotripium |
| corticosteroids | decrease inflammation, inhalers are used in a stepwise approach; SABA, LABA, SAMA, LAMA, corticosteroid then combination inhaler |
| phosphodiesterase inhibitor | for severe copd and chronic bronchitis; roflumilast |
| long term o2 therapy improves | survival, exercise capacity, cognitive performance, sleep |
| nasal cannula | patient's can eat, talk and cough; most common and comfortable |
| simple face mask | low flow system, delivers 5 - 8L/min = 40 - 60% fiO2 depending on fit and oxygen flow; never run at less than 5LPM or CO2 may buildup in mask; must remove to eat and oral care |
| non rebreather | valves going to the reservoir bag prevent CO2 being re inhaled, highest FiO2 without becoming invasive (intubation) |
| venturi mask | delivers precise amount of oxygen by use of adapters or dial selector making it most accurate non invasive method; liter flow as indicated on the dial or adapter, no humidification necessary |
| goal of pursed breathing | prolong exhalation and increase airway pressure during expiration; improves oxygen transport; do not puff cheeks |
| airway clearance technique | loosen mucus and secretions to be cleared by coughing, huff coughing |
| chest physiotherapy | postural drainage (2-4 x/day), percussion, vibration |
| copd malnutrition | increased metabolic rate, lack of appetite, altered taste, weight loss |
| goals for copd | reduce symptoms, reduce risk, prevent progression |
| lung volume reduction surgery (LVRS) | reduce size of hyper inflated lungs, decrease airway obstruction and increase room for normal alveoli |
| bronchoscopy lung volume reduction surgery | valves used for endoscopic lung volume reduction; removable one way flow devices placed by flexible bronchoscopy into selected airways supplying emphysematous lung |
| pulmonary hypertension | elevated pulmonary arterial pressure from a increase in resistance to blood flow through the pulmonary circulation |
| normal pulmonary pressure | 12 - 16 mmHg |
| risk factors for pulmonary hypertension | 30 - 60 years of age, higher among women, history of blood clots, diseases that change the chest wall, hepatitis b or c, liver disease and thyroid disease |
| idiopathic PAH | cause unknown, injury to endothelium leads to vascular scarring, smooth muscle proliferation and endothelial dysfunction |
| manifestations of idiopathic | dyspnea on exertion, fatigue, exertional chest pain, dizziness; with progression abnormal s3 heart sound or ventricular gallop |
| secondary pulmonary hypertension | chronic increase in artery pressures from another disease |
| assessment findings secondary PAH | RV hypertrophy, s4 or atrial gallop, peripheral edema, increased peripheral venous pressure, hepatomegaly because the portal vein is unable to circulate |
| chest x ray PAH | visualize pulmonary system, hypertrophy of heart; reveals no vasculature, this is to rule out other disease process and see enlargement of the heart |
| BNP | hormone, an increase reflects heart failure |
| transthoracic echocardiogram (TTE) | ultrasound looks at blood flow and measures pressures in the heart; mean pulmonary artery pressure; will report ejection fraction - normal 55 - 70% |
| pulmonary functions test | look for other underlying conditions, COPD, pulmonary fibrosis |
| right heart catheterization | accurate measurement of right atrial pulmonary artery pressure, cardiac output and pulmonary vascular resistance |
| cath procedure | catheter is placed in the femoral, internal jugular or subclavian veins and advances into the vena cava into the right atrium; balloon is inflated on the tip of the catheter and wedges in the pulmonary artery |
| calcium channel blockers for PAH | cause blood vessels to relax and widen, lowers artery pressure - dilitazem or amlodipine |
| CCB teach | count HR and check BP, change position slowly, bad headaches because blood vessels in the brain vasodilate |
| endothelin receptor antagonists PAH | block the constriction of pulmonary arteries, relaxing and decreasing the pressure; need to monitor LFT; bosentan |
| phosphodiesterase inhibitors PAH | promote smooth muscle relaxation in lung vasculature; side effects of hypotension and bradycardia; sildenafil |
| inhaled vasodilators PAH | dilates systemic and pulmonary arterial vasculature; nebulizer 6 - 9 days; need to check BP; iloprost |
| parenteral vasodilators PAH | reduces pulmonary vascular resistance, continuous IV or subcutaneous, short half life; education is essential; epoprostenol |
| diuretics PAH | used to manage peripheral edema |
| anticoagulants PAH | prevent thrombus formation; patients are at risk for blood clots in the small arteries in the lungs |
| pulmonary thromboendarterectomy | removes clots from the pulmonary arteries |